Searched for
GAMALEYA INSTITUTE
Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: StudyThe study was conducted at the Italian Spallanzani Institute on comparable groups of sera from individuals vaccinated with Sputnik V and Pf...- Sputnik V protects two times more against Covid than Pfizer's vaccine: StudySputnik V in a statement on Thursday said that as per an independent comparative study conducted by the Spallanzani institute in Italy, its...
- Omicron variant could replace Delta strain globally: Head of Russian Gamaleya InstituteAccording to the Gamaleya institute director, the effectiveness of the Russian Sputnik V vaccine against the Omicron strain will be tested ...
- Gap between Sputnik V COVID-19 shots can be up to 180 days - Russia's RDIFAn official at the RDIF, which markets the vaccine abroad, made the comments in a statement after some countries decided to widen the gap b...
- Sputnik V is safest among all COVID-19 vaccines, no deaths recorded: Buenos Aires studyThere were no deaths related to the Russian vaccine, and most post-vaccination events were mild, such as fever, headaches, and pain at the ...
- WHO team raises concerns on Sputnik V filling plant in Russia: Issues addressed, says companyPharmstandard-UfaVITA, the firm that fills the vaccine (Gam COVID-Vac), said it has addressed all the issues raised by the WHO inspection t...
- Haryana Cabinet to decide on Malta-based company's offer for selling Sputnik-V vaccinesMalta-headquartered Pharma Regulatory Services Limited has given an expression of interest to the state-run HMSCL to provide doses of Sputn...
- Serum Institute gets DCGI's nod to manufacture Sputnik V in India for test, analysis"The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and anal...
- Russia repeats 91.4% efficacy rate in new COVID-19 vaccine data: DevelopersThe new results are based on data from 22,714 participants in the trial, and were published after 78 confirmed coronavirus cases were repor...
- AstraZeneca to test combining COVID-19 vaccine with Russian shotThe developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.
- Russia approves second coronavirus vaccine after early trialsThe peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia and tested among 100 volunteers in earl...
- India’s coronavirus vaccine pipeline could be one of the largest in the world“Nationally, nearly 30 Covid-19 vaccine candidates are under development, by both industry and academia. These vaccines are in different st...
- Russia looking for partnership with India for producing COVID-19 vaccine Sputnik: RDIF CEOSputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. The vaccine has not ...
- Russia starts production of coronavirus vaccine, shows reportRussia has said the vaccine, developed by Moscow's Gamaleya Institute and the first for the coronavirus to go into production, will be roll...
- Indian pharma producers show great interest in Covid-19 vaccine Sputnik V: Russian sovereign wealth fundThe RDIF has funded research and production of Sputnik V, the world’s first approved coronavirus vaccine, developed by the Moscow-based Gam...
- Russia not world's first to develop coronavirus vaccine: Kiran Mazumdar-ShawThe world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairp...
- Russia plans to register the world's first coronavirus vaccine on August 12"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trial...
- Russia aims to launch mass production of coronavirus vaccine doses by 2021The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stag...
- Russia plans mass vaccination against coronavirus from October, health workers first in lineA source told Reuters this week that Russia's first potential COVID-19 vaccine, developed by a state research facility, would secure local ...
- Search for solution: Russia plans to register first coronavirus vaccine by August 12The drug developed by Moscow’s Gamaleya Institute and the Russian Direct Investment Fund may be approved for civilian use within three to s...
Load More
